MCINTYRE GAIL FRANCES (Chief Scientific Officer) received a stock award from ARAVIVE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/26/2022ACC: 0001437749-22-024811
Officer· Chief Scientific Officer
Since Feb 2019
+108.71K
Net shares
Net buyer
$50.0K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
108.71K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+54.35K
Price / share
$0.92
Trade value
$50K
% of position
488.0%
10/24/2022
11.14K→65.49K
Total
Net shares
+54.35K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 10/24/2022 | A · Award | +54.35K | $0.92 | $50K | 488.0% | 11.14K | 65.49K |
| Total | +54.35K | $50K | ||||||
Derivative Transactions2
Series A Warrants (right to buy)
Direct
Converts to
Common stock
27.18K shares
Shares
+27.18K
Strike price
0.7949
Held after
27.18K
Exercisable
—
10/24/2022
Series B Warrants (right to buy)
Direct
Converts to
Common stock
27.18K shares
Shares
+27.18K
Strike price
0.7949
Held after
27.18K
Exercisable
—
10/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrants (right to buy) Direct | Common stock27.18K shares | 10/24/2022 | A · Award | +27.18K | 0.7949 | — | 27.18K |
| Series B Warrants (right to buy) Direct | Common stock27.18K shares | 10/24/2022 | A · Award | +27.18K | 0.7949 | — | 27.18K |